Universal health coverage and accomplishment of secondary prevention goals among patients with acute myocardial infarction;Prevención secundaria post infarto agudo de miocardio en hospitales públicos: Implementación y resultados de las garantías ges

Revista Medica de Chile

Volumn 141, Issue 8, 2013, Pages 977-986

  Nazzal, Carolina ^a   Lanas, Fernando ^b   Garmendia, María Luisa ^a   Bugueño, Claudio ^c   Mercadal, Enrique ^d   Garcés, Eduardo ^e   Yovaniniz, Patricio ^f   Sanhueza, Patricio ^g  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

^c Hospital Regional La Serena   (Chile)

^d HOSPITAL REGIONAL DE TALCA   (Chile)

^e Hospital Regional Valdivia ^*  (Chile)

^f HOSPITAL BARROS LUCO TRUDEAU   (Chile)

^g Hospital San Juan de Dios   (Chile)

Author keywords

Anterior wall myocardial infarction; Chile; Practice guideline; Quality of health care; Secondary prevention; Universal coverage

Indexed keywords

ACUTE DISEASE; AGED; ARTICLE; CHILE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INSURANCE; LIFESTYLE; MALE; METHODOLOGY; MIDDLE AGED; PROGRAM EVALUATION; PUBLIC HOSPITAL; REGISTER; RISK FACTOR; SECONDARY PREVENTION; STATISTICS;

ACUTE DISEASE; AGED; CHILE; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PUBLIC; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGRAM EVALUATION; REGISTRIES; RISK FACTORS; SECONDARY PREVENTION; UNIVERSAL COVERAGE;

EID: 84892568922     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872013000800003     Document Type: Article

References (50)

1. Bases de defunciones 2010 [citado el 2 de noviembre de 2012]. Disponible en: http:www.deis.cl.
2. Departamento de Epidemiología. Estudio carga de enfermedad y carga atribuible 2007. 2008 [citado el 12 de noviembre de 2012]; Disponible en: http://epi.minsal.cl/epi/html/invest/cargaenf2008/minuta21-07-2008.pdf.
3. Ministerio de Salud de Chile. Los Objetivos Sanitarios para la Década 2000-2010 Evaluación de final del período, Grado de cumplimiento de los objetivos de Impacto. 2010 [citado el 9 de diciembre de 2010]; Disponible en: http://epi.minsal.cl/epi/html/sdesalud/OS/EvaluacionObjetivosSanitarios2000-2010.pdf.
4. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295 (2): 180-9.
5. De Bacquer D, De Backer G, Ostor E, Simon J, Pyorala K. Predictive value of classical risk factors and their control in coronary patients: a follow-up of the EUROASPIRE I cohort. Eur J Cardiovasc Prev Rehabil 2003; 10 (4): 289-95.
6. Hosokawa S, Hiasa Y, Miyazaki S, Ogura R, Miyajima H, Ohara Y, et al. Effects of smoking cessation on coronary endothelial function in patients with recent myocardial infarction. Int J Cardiol 2008; 128 (1): 48-52.
7. Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004; 110 (18): 2952-67.
8. Todd Miller M, Lavie CJ, White CJ. Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr 2008; 3 (3): 162-7.
9. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet; 375 (9733): 2215-22.
10. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007; 115 (21): 2761-88.
11. Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 2010; 121 (6): 750-8.
12. Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005; 143 (9): 659-72.
13. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004 (1): CD003041.
14. Gerber Y, Rosen LJ, Goldbourt U, Benyamini Y, Drory Y. Smoking status and long-term survival after first acute myocardial infarction a population-based cohort study. J Am Coll Cardiol 2009; 54 (25): 2382-7.
15. Iestra JA, Kromhout D, van der Schouw YT, Grobbee DE, Boshuizen HC, van Staveren WA. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation 2005; 112 (6): 924-34.
16. Bramlage P, Messer C, Bitterlich N, Pohlmann C, Cuneo A, Stammwitz E, et al. The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart; 96 (8): 604-9.
17. Chew DP, Huynh L, Astley C, Liew D, Soman A, Brieger D. Potential Survival Gains in the Treatment of Myocardial Infarction. Heart 2009 Aug 6.
18. Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318 (7200): 1730-7.
19. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29 (23): 2909-45.
20. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999; 282 (24): 2340-6.
21. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376 (9753): 1670-81.
22. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006 May 16; 113 (19): 2363-72.
23. Piepoli MF, Corra U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2010; 17 (1): 1-17.
24. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116 (10): 682-92.
25. Dalal HM, Zawada A, Jolly K, Moxham T, Taylor RS. Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis. BMJ 2010; 340: b5631.
26. Ley 19.966: ESTABLECE UN REGIMEN DE GARANTIAS EN SALUD, (2005). Disponible en: http://www.redsalud.gov.cl/archivos/guiasges/GES_2007_final.pdf
27. Ministerio de Salud de Chile. Guía Clínica Infarto Agudo del Miocardio y Manejo del Dolor Torácico en Unidades de Emergencia 2005. 2005 [citado el 2 de noviembre de 2012]; Disponible en: http://www.redsalud.gov.cl/archivos/saludcardiovascular/INFARTOAGUDO.pdf.
28. Ministerio de Salud Gobierno de Chile. Implementación del enfoque de riesgo en el Programa de Salud Cardiovascular. [citado el 9 de noviembre de 2012]; Disponible en: http://www.redsalud.gov.cl/portal/url/item/787e4765248bc9e0e04001011f0172b5.pdf.
29. Nazzal NC, Campos TP, Corbalan HR, Lanas ZF, Bartolucci JJ, Sanhueza CP, et al. Impacto del plan AUGE en el tratamiento de pacientes con infarto agudo al miocardio con supradesnivel ST, en hospitales chilenos. Rev Med Chile 2008; 136 (10): 1231-9.
30. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation 2007; 116 (22): 2634-53.
31. Kotseva K. Treatment of patients with coronary heart disease fails to meet standards of european guidelines: results of EUROASPIRE surveys. Rev Esp Cardiol 2009; 62 (10): 1095-8.
32. Ministerio de Salud Gobierno de Chile. Guía Clínica infarto agudo del miocardio con supradesnivel del segmento st. 2010; 2009 [citado el 13 de noviembre de 2012]; Disponible en: http://www.redsalud.gov.cl/portal/url/item/72213ed52c3323d1e04001011f011398.pdf.
33. Ministerio de Salud de Chile. Guía Clínica 2009 Hipertensión Arterial Primaria o esencial en personas de 15 años y más. Febrero de 2010; [citado el 13 de noviembre de 2012]; Disponible en: http://www.redsalud.gov.cl/portal/url/item/7220fdc4341c44a9e04001011f0113b9.pdf.
34. Vulic D, Lee BT, Dede J, López VA, Wong ND. Extent of Control of Cardiovascular Risk Factors and Adherence to Recommended Therapies in US Multiethnic Adults with Coronary Heart Disease: From a 2005-2006 National Survey. Am J Cardiovasc Drugs 2010; 10 (2): 109-14.
35. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373 (9667): 929-40.
36. Cacoub PP, Zeymer U, Limbourg T, Baumgartner I, Poldermans D, Rother J, et al. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart 2011; 97 (8): 660-7.
37. Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001; 87 (7): 819-22.
38. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Díaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011; 378 (9798): 1231-43.
39. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113 (6): 898-918.
40. Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO. The obesity paradox, weight loss, and coronary disease. Am J Med 2009; 122 (12): 1106-14.
41. Trzos E, Kurpesa M, Rechcinski T, Wierzbowska-Drabik K, Krzeminska-Pakula M. The influence of physical rehabilitation on arterial compliance in patients after myocardial infarction. Cardiol J 2007; 14 (4): 366-71.
42. Boraita A. Ejercicio, piedra angular de la prevención cardiovascular. Rev Esp Cardiol 2008; 61: 514-28.
43. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136 (7): 493-503.
44. Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, et al. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation 2011; 123 (10): 1138-43.
45. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344 (1): 3-10.
46. Pedrinelli R, Ballo P, Fiorentini C, Denti S, Galderisi M, Ganau A, et al. Hypertension and acute myocardial infarction: an overview. J Cardiovasc Med (Hagerstown). 2012; 13 (3): 194-202.
47. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332 (7533): 73-8.
48. Bartnik M, Ryden L, Malmberg K, Ohrvik J, Pyorala K, Standl E, et al. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Heart 2007; 93 (1): 72-7.
49. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011; 124 (22): 2458-73.
50. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Rev Esp Cardiol 2009; 62 (3): 293.